Bayesian MCMC Analysis on R&D Investment of Biotech Start-up in the ‘Valley of Death’

Takao Fujiwara
Additional contact information
Takao Fujiwara: Institute of Liberal Arts and Sciences, Toyohashi University of Technology, Toyohashi, Japan

Technology Transfer and Entrepreneurship, 2016, vol. 3, issue 2, 119-130

Abstract: In addition to many need-pull innovations, a type of rare basic-research-push innovation is biopharmaceutical development. In reflecting next generation innovation, the NASDAQ Biotechnology Index (NBI) is actually moving stronger in comparison with other indicators. From the industry’s high dependence on basic research, biotech start-up, which is more excellent in combing breakthrough technologies and niche markets than the mass market and low risk-oriented large pharmaceutical companies are expected as a major driver of the innovation chain. However, from the prolonging period of pharmaceutical development, expansion of necessary investment, low possibility of success, and severe resource constraints, a drug discovery-based biotech start-up must endure the ‘Valley of Death’ as a long-term deficit state in addition to the high bankruptcy rate. Why can a biotech start-up that suffers from long-term deficits even in the financial crisis continue research and development investment? If so, what kind of criteria for investment can be utilized? Biotech start-up is defined as the portfolio of real options. As methodologies, this paper applies the real options concept to the assessment of the stockholders’ equity as technological potential and Bayesian MCMC to the parameter estimation between the net income, shareholders' equity value, and R&D costs of representative 30 companies in the NBI.

Keywords: Biotech start-up; Valley of Death; R&D investment; real options analysis; Bayesian Markov Chain Monte Carlo (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.eurekaselect.com/143955/article (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ben:ttebsp:v:3:y:2016:i:2:p:119-130

DOI: 10.2174/2213809903666160714112610

Access Statistics for this article

More articles in Technology Transfer and Entrepreneurship from Bentham Science Publishers
Bibliographic data for series maintained by Rehana Raza ( this e-mail address is bad, please contact ).